| Income Statement |
| Total Revenue | 55.53M |
|
| Revenues (USD) | 55.53M |
| Cost of Revenue | 22.79M |
| Gross Profit | 32.74M |
| Operating Expenses | 7.67M |
| Research and Development Expense | 2.31M |
| Selling, General and Administrative Expense | 5.22M |
| Operating Income | 25.08M |
| Income Tax Expense | 7.18M |
| Net Income | 20.41M |
| Net Income Common Stock | 20.41M |
| Net Income Common Stock (USD) | 20.41M |
| Consolidated Income | 20.41M |
| Earnings per Basic Share | 0.22 |
| Earnings per Basic Share (USD) | 0.22 |
| Earnings per Diluted Share | 0.22 |
| Earning Before Interest & Taxes (EBIT) | 27.59M |
| Earning Before Interest & Taxes (USD) | 27.59M |
| Weighted Average Shares | 90.91M |
| Balance Sheet |
| Cash and Equivalents | 231.38M |
| Cash and Equivalents (USD) | 231.38M |
| Investments | 98.52M |
| Investments Non-Current | 98.52M |
| Trade and Non-Trade Receivables | 27.81M |
| Current Assets | 260.93M |
| Property, Plant & Equipment Net | 16.84M |
| Total Assets | 379.77M |
| Debt Current | 2.45M |
| Total Debt | 6.93M |
| Current Liabilities | 98.58M |
| Debt Non-Current | 4.48M |
| Total Liabilities | 104.83M |
| Accumulated Retained Earnings (Deficit) | 45.82M |
| Accumulated Other Comprehensive Income | -361.00K |
| Shareholders Equity | 274.94M |
| Shareholders Equity (USD) | 274.94M |
| Assets Non-Current | 118.84M |
| Total Debt (USD) | 6.93M |
| Deferred Revenue | 73.67M |
| Liabilities Non-Current | 6.25M |
| Trade and Non-Trade Payables | 13.06M |
| Tax Assets | 2.91M |
| Tax Liabilities | 9.39M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 730.00K |
| Net Cash Flow from Financing | -57.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -73.99M |
| Capital Expenditure | -327.00K |
| Net Cash Flow from Investing | -99.32M |
| Net Cash Flow - Investment Acquisitions and Disposals | -98.99M |
| Net Cash Flow from Operations | 25.47M |
| Effect of Exchange Rate Changes on Cash | -85.00K |
| Share Based Compensation | 740.00K |